A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS
Clinical trial NCT04121221 · COMPLETED
Trial details
- NCT number
- NCT04121221
- Sponsor
- Mapi Pharma Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-19
- Primary completion
- 2023-06-13
- Enrollment
- 1016
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.